 |
会社説明会 |
 |
 |
 |
|
 |
FY2018 Financial Results (April 2018 - March 2019)
|
|
|
 |
 |
 |
President and CEOIsao Teshirogi, Ph.D.
|
|
 |
|
 |
 |
 |
 |
|
 |
2018年度 決算説明会 (2019年05月10日開催)
|
|
|
 |
 |
 |
President and CEO Isao Teshirogi ,Ph.D
Senior Vice President Pharmaceutical Research Division Takeshi Shiota ,Ph.D Senior Executive Officer, Senior Vice President,CMC R&D Division Ryuichi Kume ,Ph.D., Corporate Officer, Senior Vice President,Global Development Division Toshinobu Iwasaki ,Ph.D.,
|
|
 |
|
 |
 |
 |
 |
代表取締役社長 手代木 功
医薬研究本部長 塩田 武司
CMC研究本部長 久米 龍一
医薬開発本部長 岩 利信
|
|
 |
|
 |
 |
 |
 |
|
 |
3rdQuarter of Fiscal 2018 Financial Results Conference Call
|
|
|
 |
 |
 |
Kohji Hanasaki, Ph.D. Senior Executive Officer, Senior Vice President, Finance & Accounting Department
Kenji Matsuo Vice President, Finance & Accounting Department
|
|
 |
|
 |
 |
 |
 |
|
 |
2018年度第3四半期決算 Conference Call (2019年1月31日開催)
|
|
|
 |
 |
 |
上席執行役員 経営戦略本部長 花 浩二
経理財務部長 松尾 健二
|
|
 |
|
 |
 |
 |
 |
|
 |
1st Half of Fiscal 2018 Financial Results
|
|
|
 |
 |
 |
Isao Teshirogi, Ph.D. President and CEO
|
|
 |
|
 |
 |
 |
 |
|
 |
2018年度 第2四半期(上期) 決算説明会 (2018年10月30日開催)
|
|
|
 |
 |
 |
|
 |
1st Quarter of Fiscal 2018 Financial Results Conference Call
|
|
|
 |
 |
 |
Takuko Sawada Director, Executive Vice President
Kohji Hanasaki, Ph.D. Senior Executive Officer, Senior Vice President, Finance & Accounting Department Kenji MatsuoVice President, Finance & Accounting DepartmentKenji Matsuo
|
|
 |
|
 |
 |
 |
 |
|
 |
2018年度 第1四半期決算 Conference Call(2018年07月30日開催)
|
|
|
 |
 |
 |
代表取締役副社長 澤田 拓子
上席執行役員 経営戦略本部長 花 浩二 経理財務部長 松尾 健二
|
|
 |
|
 |
 |
 |
 |
|
 |
FY 2017 Financial Results (April 2017-March 2018)
|
|
|
 |
 |
 |
Isao Teshirogi, Ph. D. President and CEO
|
|
 |
|
 |
 |
 |
 |
|
 |
2017年度 決算(2017年4月〜2018年3月)(2018年05月10日開催)
|
|
|
 |
 |
 |
President and CEO Isao Teshirogi, Ph.D.
Director of the Board, Senior Executive Officer, Senior Vice President, Corporate Strategy Takuko Sawada Senior Vice President, Pharmaceutical Research Division Takeshi Shiota, Ph.D. Senior Vice President, CMC Development Laboratories Miyuki Hiura, Senior Vice President, Global Development Division Kazuhiro Hatanaka, Vice President, Corporate Communications Hiroki Takagi
|
|
 |
|
 |
 |
 |
 |
代表取締役社長 手代木 功
取締役上席執行役員 経営戦略本部長 澤田 拓子
医薬研究本部長 塩田 武司
CMC研究本部長 日裏 深雪
医薬開発本部長 畑中 一浩
広報部長 高木 浩樹
|
|
 |
|
 |
 |
 |
 |
|
 |
3rd Quarter of Fiscal 2017 Financial Results Conference Call
|
|
|
 |
 |
 |
Director of the Board, Senior Executive Officer, Senior Vice President, Corporate Strategy Takuko Sawada
Senior Executive Officer, Senior Vice President, Finance & Accounting Department Kohji Hanasaki, Ph.D
|
|
 |
|
 |
 |
 |
 |
|
 |
2017年度 第3四半期決算 Conference Call (2018年02月06日開催)
|
|
|
 |
 |
 |
取締役上席執行役員 経営戦略本部長 澤田 拓子
上席執行役員 経理財務部長花 浩二
|
|
 |
|
 |
 |
 |
 |
|
 |
1st Half of Fiscal 2017 Financial Results
|
|
|
 |
 |
 |
President and CEO Isao Teshirogi, Ph.D.
Director of the Board, Senior Executive Officer, Senior Vice President, Corporate Strategy Takuko Sawada Senior Executive Officer, Senior Vice President, Finance & Accounting Department Kohji Hanasaki, Ph.D Vice President, Corporate Communications Hiroki Takagi
|
|
 |
|
 |
 |
 |
 |
|
 |
2017年度 第2四半期(上期) 決算説明会(2017年10月31日開催)
|
|
|
 |
 |
 |
代表取締役社長 手代木 功
取締役 上席専務執行役員 経営戦略本部長 澤田 拓
上席執行役員 経理財務部長 花 浩二
広報部長 高木 浩樹
|
|
 |
|
 |
 |
|